INPP5D and familial pancreatic carcinoma: Therefore, miR-155 regulation of SHIP-1 and SOCS1 expressions may be potential biomarkers and therapeutic targets for the treatment of pancreas-associated diseases (i.e., pancreatitis and pancreatic cancer).